New injection tested for autoimmune dryness disease
NCT ID NCT07041099
Summary
This early-stage study is testing the safety and side effects of an experimental drug called CLN-978 in people with active, moderate to severe Sjogren's disease. The drug is given as an injection under the skin. Researchers will enroll 36 participants to monitor for any adverse reactions and measure how the drug behaves in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SJOGREN'S SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cullinan Investigative Site
RECRUITINGPlano, Texas, 75093, United States
-
Cullinan Investigative Site
RECRUITINGSalt Lake City, Utah, 84107, United States
-
Cullinan Investigative Site
RECRUITINGErlangen, Germany
Conditions
Explore the condition pages connected to this study.